Back to search

Total Citations Per Year

Abstract

References (18)

A new class of angiotensin-converting enzyme inhibitors

1980 • 704 citations

Captopril-Induced Functional Renal Insufficiency in Patients with Bilateral Renal-Artery Stenoses or Renal-Artery Stenosis in a Solitary Kidney

1983 • 658 citations

Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.

1982 • 243 citations

Enalapril maleate and a lysine analogue (MK‐521): disposition in man.

1982 • 213 citations

ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421".

1981 • 189 citations

Antihypertensive Therapy with MK 4211

1982 • 188 citations

Disposition of captopril in normal subjects

1980 • 161 citations

Three new long-acting converting-enzyme inhibitors: Relationship between plasma converting-enzyme activity and response to angiotensin I

1981 • 146 citations

Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.

1981 • 146 citations

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.

1981 • 124 citations

Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor.

1981 • 119 citations

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects

2004 • 114 citations

Effects of enalapril, a new converting enzyme inhibitor, in hypertension

1982 • 83 citations

Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects.

1981 • 70 citations

Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats

1981 • 45 citations

"Scalded mouth" caused by angiotensin-converting-enzyme inhibitors.

1982 • 34 citations

Reversal of diuretic-induced secondary hyperaldosteronism and hypokalemia by enalapril (MK-421): A new angiotensin-converting enzyme inhibitor

1983 • 24 citations

Altered Fractional Tetrahydroaldosterone Excretion during Pharmacological Blockade and Activation of the Renin-Aldosterone System*

1982 • 7 citations

Cited By (0)

Loading...
Enalapril Worldwide Experience (1984) – The American Journal of Medicine | Metascience Observatory Explorer